About Cytosolic non-specific dipeptidase
Cytosolic non-specific dipeptidase (CNDP2) is a protein
from Homo sapiens identified by UniProt accession
Q96KP4, 475 residues long.
MolForge cross-references it against 0 known binders and
72 disease associations.
Target properties
| Protein name | Cytosolic non-specific dipeptidase |
| UniProt accession | Q96KP4 |
| Gene | CNDP2 |
| Organism | Homo sapiens |
| Length | 475 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (72)
Diseases linked to this target (Open Targets).
- serum metabolite measurement · score 0.45
- refractive error · score 0.39
- body height · score 0.31
- Abnormality of refraction · score 0.31
- refractive error measurement · score 0.29
- glioblastoma multiforme · score 0.16
- mean corpuscular volume · score 0.13
- metabolite measurement · score 0.09
- blood protein measurement · score 0.05
- Hepatic veno-occlusive disease - immunodeficiency · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96KP4-F1 | alphafold | PREDICTED | 97.78 | — |
Amino-acid sequence (475 residues)
MAALTTLFKY IDENQDRYIK KLAKWVAIQS VSAWPEKRGE IRRMMEVAAA DVKQLGGSVE LVDIGKQKLP DGSEIPLPPI LLGRLGSDPQ KKTVCIYGHL DVQPAALEDG WDSEPFTLVE RDGKLYGRGS TDDKGPVAGW INALEAYQKT GQEIPVNVRF CLEGMEESGS EGLDELIFAR KDTFFKDVDY VCISDNYWLG KKKPCITYGL RGICYFFIEV ECSNKDLHSG VYGGSVHEAM TDLILLMGSL VDKRGNILIP GINEAVAAVT EEEHKLYDDI DFDIEEFAKD VGAQILLHSH KKDILMHRWR YPSLSLHGIE GAFSGSGAKT VIPRKVVGKF SIRLVPNMTP EVVGEQVTSY LTKKFAELRS PNEFKVYMGH GGKPWVSDFS HPHYLAGRRA MKTVFGVEPD LTREGGSIPV TLTFQEATGK NVMLLPVGSA DDGAHSQNEK LNRYNYIEGT KMLAAYLYEV SQLKD
Explore Cytosolic non-specific dipeptidase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets